Home › Interstitial Lung Diseases › Kansas › Kansas City
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Kansas City, KS
Isang pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Kansas City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Nagre-recruitPhase 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Nagre-recruitPhase 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitPhase 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Nagre-recruitPhase 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitObservasyonal na pag-aaral
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Nagre-recruitPhase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Nagre-recruitPhase 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
Nagre-recruitObservasyonal na pag-aaral
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Nagre-recruitObservasyonal na pag-aaral
- University of Kansas, Kansas City
Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod
- New York City, NY18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Los Angeles, CA14 pag-aaral
- Charleston, SC13 pag-aaral
- Durham, NC13 pag-aaral
- Chicago, IL12 pag-aaral
- Houston, TX12 pag-aaral
- Aurora, CO11 pag-aaral
- Ann Arbor, MI11 pag-aaral
- Dallas, TX9 pag-aaral
- Salt Lake City, UT9 pag-aaral
- Boston, MA9 pag-aaral
Iba pang pag-aaral sa Kansas City
- Sakit sa Puso at Ugat ng Dugo14 pag-aaral
- Pagkabigo ng Puso13 pag-aaral
- Obesity13 pag-aaral
- Cystic Fibrosis13 pag-aaral
- Kanser sa Suso12 pag-aaral
- Kanser sa Pantog12 pag-aaral
- Acute Myeloid Leukemia12 pag-aaral
- Kanser sa Prostate12 pag-aaral
- Non-Small Cell Lung Cancer11 pag-aaral
- Kanser sa Baga11 pag-aaral
- COPD9 pag-aaral
- Asthma8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.